Company profile

CatenaBio company profile

CatenaBio pioneers protein conjugation technologies for novel therapeutic development. The company focuses on creating innovative, personalized therapeutics using its proprietary CysTyr™ technology. This technology allows precise connection to any site on a protein, facilitating the development of multi-payload conjugates. CatenaBio's advancements have potential applications in biological therapeutics, autoimmune disorders, and vaccine development.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2020-01-01

Headquarters

Headquarters
Berkeley, California, United States
Postal code
94720
Country code
US
Continent
North America

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.